Oral olesoxime vs placeboTime from beginning of treatment until death or full‐time ventilation · non‐ambulatory children and adolescents with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 160 participantsModerate